1,000
Participants
Start Date
September 6, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2026
CleoDX ovarian cancer test
A diagnostic test to assist in predicting risk of malignancy prior to surgery for patients with an adnexal mass.
RECRUITING
Virginia Women's Health Associates, Annandale
RECRUITING
Emerald Coast Clinical Research, Panama City
RECRUITING
The Jackson Clinic, Jackson
RECRUITING
Prime Clinical Research - Lewisville, Lewisville
RECRUITING
Vast Clinical Research-Holy Cross, Mesquite
RECRUITING
Next Innovative Clinical Research, Houston
RECRUITING
New Horizons Clinical Trials, Chandler
RECRUITING
Women's Cancer Center of Nevada, Las Vegas
Lead Sponsor
Collaborators (1)
Lindus Health
INDUSTRY
Cleo Diagnostics Ltd
INDUSTRY